Patient based method of assessing adverse events in clinical trials in rheumatology: The revised stanford toxicity index

Journal of Rheumatology

Volumn 28, Issue 5, 2001, Pages 1188-1191

  Welch, V ^a   Singh, G ^a   Strand, V ^a   Fries, J ^a   Boers, M ^a   Ramey, D ^a   Day, R O ^a   Brooks, P ^a   Tugwell, P ^a   Clinch, J ^a   Kristjansson, B ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Adverse events; Clinical importance; Patient ratings; Questionnaire; Toxicity

Indexed keywords

ANTIRHEUMATIC AGENT;

CONFERENCE PAPER; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; RATING SCALE; RHEUMATIC DISEASE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIRHEUMATIC AGENTS; CLINICAL TRIALS; HUMANS; QUESTIONNAIRES; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 0035002513     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome measures in rheumatology
2. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial
3. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
4. Etanercept therapy in rheumatoid arthritis. A randomized controlled trial
5. Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists
6. Randomized trials with quality of life endpoints: Are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?
7. Validity of a new quality of life scale for functional dyspepsia: A United States multicenter trial of the Nepean Dyspepsia Index
8. A toxicity index for comparison of side effects among different drugs
9. The patient oriented symptoms index: The POSI
10. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trial
11. Level of agreement between parents and children in rating dysfunction in juvenile arthritis and juvenile spondyloarthritides
12. The juvenile arthritis quality of life questionnaire - Development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides
13. The OMERACT filter for outcome measures in rheumatology
14. ARAMIS and toxicity measurement